Clinical Trial Update: Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating short-term aliskiren treatment in kidney transplant patients was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Kidney Disease, Kidney Failure, Chronic | Phase 4 | Status: TERMINATED | Results posted: 2017-05-01